Stephen Eppler

542 total citations
9 papers, 404 citations indexed

About

Stephen Eppler is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stephen Eppler has authored 9 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stephen Eppler's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Liver physiology and pathology (2 papers) and Coronary Interventions and Diagnostics (2 papers). Stephen Eppler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Liver physiology and pathology (2 papers) and Coronary Interventions and Diagnostics (2 papers). Stephen Eppler collaborates with scholars based in United States, Japan and France. Stephen Eppler's co-authors include Nishit B. Modi, René Bruno, Mathilde Marchand, Jane Ruppel, Oyewale O. Abidoye, Damon I. Papac, John B. Briggs, Vanessa Chisholm, Martin Gawlitzek and Kate S. Carroll and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Stephen Eppler

9 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Eppler United States 8 188 143 99 65 45 9 404
Raimondo Di Giacomo Italy 10 78 0.4× 87 0.6× 72 0.7× 17 0.3× 50 1.1× 24 384
Natalia Zabalegui Spain 13 203 1.1× 264 1.8× 140 1.4× 261 4.0× 40 0.9× 20 621
Vincenzo Rosario Iaffaioli Italy 15 134 0.7× 314 2.2× 66 0.7× 66 1.0× 34 0.8× 25 519
Jun Ji China 15 285 1.5× 202 1.4× 53 0.5× 115 1.8× 174 3.9× 29 673
Masaaki Jibiki Japan 12 203 1.1× 181 1.3× 59 0.6× 83 1.3× 47 1.0× 35 436
Seok-Hyun Kim South Korea 8 250 1.3× 191 1.3× 19 0.2× 67 1.0× 64 1.4× 16 447
Claudia von Arx Italy 11 100 0.5× 219 1.5× 56 0.6× 32 0.5× 22 0.5× 31 461
Tao Osgood United States 6 158 0.8× 185 1.3× 20 0.2× 27 0.4× 51 1.1× 14 308
Kimihiro Ito Japan 12 185 1.0× 156 1.1× 60 0.6× 57 0.9× 79 1.8× 26 482
Valerie Relias United States 11 139 0.7× 161 1.1× 68 0.7× 182 2.8× 17 0.4× 32 463

Countries citing papers authored by Stephen Eppler

Since Specialization
Citations

This map shows the geographic impact of Stephen Eppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Eppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Eppler more than expected).

Fields of papers citing papers by Stephen Eppler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Eppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Eppler. The network helps show where Stephen Eppler may publish in the future.

Co-authorship network of co-authors of Stephen Eppler

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Eppler. A scholar is included among the top collaborators of Stephen Eppler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Eppler. Stephen Eppler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Stroh, Mark, Helen Winter, Mathilde Marchand, et al.. (2016). Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma. Clinical Pharmacology & Therapeutics. 102(2). 305–312. 116 indexed citations
2.
Han, Kelong, Jin Y. Jin, Mathilde Marchand, et al.. (2015). Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 76(5). 917–924. 22 indexed citations
3.
4.
Yan, Xin, Stephen Eppler, Lisa A. Damico‐Beyer, et al.. (2013). Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumors. The Journal of Clinical Pharmacology. 53(11). 1103–1111. 33 indexed citations
5.
Moss, Rebecca A., John Bothos, Ellen Filvaroff, et al.. (2010). Phase Ib dose-escalation study of MetMAb, a monovalent antagonist antibody to the receptor MET, in combination with bevacizumab in patients with locally advanced or metastatic solid tumors.. Journal of Clinical Oncology. 28(15_suppl). e13050–e13050. 8 indexed citations
6.
7.
Papac, Damon I., John B. Briggs, Martin Gawlitzek, et al.. (1999). Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nature Biotechnology. 17(11). 1116–1121. 147 indexed citations
8.
9.
Eppler, Stephen, et al.. (1998). Pharmacokinetics of a Slower Clearing Tissue Plasminogen Activator Variant, TNK-tPA, in Patients with Acute Myocardial Infarction. Thrombosis and Haemostasis. 79(1). 134–139. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raimondo Di Giacomo Breakdown of academic impact, for papers by Natalia Zabalegui Breakdown of academic impact, for papers by Vincenzo Rosario Iaffaioli Breakdown of academic impact, for papers by Jun Ji Breakdown of academic impact, for papers by Masaaki Jibiki Breakdown of academic impact, for papers by Seok-Hyun Kim Breakdown of academic impact, for papers by Claudia von Arx Breakdown of academic impact, for papers by Tao Osgood Breakdown of academic impact, for papers by Kimihiro Ito Breakdown of academic impact, for papers by Valerie Relias
Rankless by CCL
2026